• Google

    Ribociclib Effective in Younger Breast Cancer Patients Too - Medscape /Link


    Medscape

    Ribociclib Effective in Younger Breast Cancer Patients Too
    Medscape
    SAN ANTONIO — The CDK4/6 inhibitor ribociclib (Kisqali, Novartis) dramatically improves progression-free survival (PFS) when added to endocrine therapy in ovarian-suppressed younger patients with hormone receptor-positive (HR+), human epidermal ...
    For Breast Cancer Patients, Less Time on Hormonal Meds?HealthDay
    SABCS: I-SPY 3-year pCR results are powerful predictor for breast cancer survivalEurekAlert (press release)
    Acupuncture Dulls Pain from Drugs to Prevent Breast Ca RecurrenceMedPage Today
    Curetoday.com -Medical Xpress -Healio -News-Medical.net
    all 128 news articles »




    Published on 08 Dec 2017 at 12:16AM








  • Recent Posts








    ^Comments